Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...
The Inference Gateway is a proxy server designed to facilitate access to various language model APIs. It allows users to interact with different language models through a unified interface, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results